HomeNewsBusinessEconomyBeing loyal to your company may not pay off during COVID-19-linked job cuts

Being loyal to your company may not pay off during COVID-19-linked job cuts

Even employees spending several years in an organisation are also not being spared during layoffs amidst COVID-19 outbreak.

July 04, 2020 / 09:15 IST
Story continues below Advertisement

What hurt 39-year-old Oindrila Guha the most, more than being laid off, was how she, the senior-most in the team, was treated by the company. Being an employee of the supply chain division at this conglomerate, Guha had worked with the group for 16 years.

“I had helped the company steer through many crisis situations in the past. So, I expected that my loyalty would pay off. Sadly, that was not the case. The company is even giving vague explanations for why I was chosen for being laid off. I am not even being given any pay package as a separation benefit which employees are typically entitled to in this company,” she added.

Story continues below Advertisement

Amidst the series of job cuts during the coronavirus outbreak, employees across firms who had presumed that their loyalty to the organisation would pay off, have been disheartened.

Follow our LIVE Updates on the coronavirus pandemic here

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show